ELEV — Elevation Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- $22.22m
- -$27.19m
Annual cashflow statement for Elevation Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.3 | -32 | -95.1 | -45.7 | -44.5 |
| Depreciation | |||||
| Non-Cash Items | 0.052 | 1.57 | 3.28 | 3.17 | 4.26 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.9 | 0.283 | 6.29 | -13.7 | 3.84 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -12.3 | -30.2 | -85.5 | -56.2 | -36.4 |
| Capital Expenditures | -0.071 | 0 | -0.086 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -44.3 | 11.5 | -8.37 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.071 | 0 | -44.4 | 11.5 | -8.37 |
| Financing Cash Flow Items | -0.174 | -0.011 | -0.47 | 0 | -0.17 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 90 | 97.1 | 29.5 | 48 | 44.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 77.7 | 66.9 | -100 | 3.34 | 0.209 |